The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Recurrence-free survival results from a pilot study of adjuvant gefitinib in resected hepatocellular carcinoma (HCC).
 
Akhil Chopra
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bayer
 
Gilberto Lopes
Honoraria - AstraZeneca; Fresenius Kabi; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Pfizer
Research Funding - AstraZeneca; Eisai; Lilly/ImClone; Merck Sharp & Dohme; Pfizer
Expert Testimony - Sanofi
 
Lavina D. Bharwani
No Relationships to Disclose
 
Chung Yip Chan
No Relationships to Disclose
 
Alexander Chung
No Relationships to Disclose
 
Peng Chung Cheow
No Relationships to Disclose
 
Choon Kiat Ho
No Relationships to Disclose
 
Kui Hin Liau
Stock and Other Ownership Interests - IHH Healthcare Berhad (I)
Travel, Accommodations, Expenses - Covidien
 
Winston Woon
No Relationships to Disclose
 
Jee Keem Low
No Relationships to Disclose
 
Alex Yuang-Chi Chang
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb